101 Munson Street,
Greenfield , MA, 01301-9668

Rank

Rank Universe
8 69

Summary

The fund seeks to invest in growth companies around the world including the United States.

The fund is sub-advised by Vontobel Asset Management with a target focus on large-size growth companies.

The investment process focuses on identifying companies with long-term economic prospects, durable business franchise and solid financial status. The research team then looks for drivers of growth and evaluates the sources of earni More

Link

Directors

Dec 13, 2023
  • Sarah E. Cogan
  • Brian T. Zino
  • Sidney E. Harris
  • R. Keith Walton
  • John R. Mallin
  • Deborah A. DeCotis
  • F. Ford Drummond
  • Philip R. McLoughlin
  • George R. Aylward
  • Connie D. McDaniel
  • Geraldine M. McNamara
  • Donald C. Burke

Chief Compliance Officer

  • Timothy Branigan

Price

  • $ 16.66 ( -0.02 )
    Mar 8, 2024
    Last Close
  • Net Assets
  • $266.6M
    Feb 28, 2024
  • Holding
  • 2
    Feb 28, 2024
    More

  • 52-Week High/Low
  • $16.98 - $13.9
  • Turnover
  • 35%
  • Expense Ratio
  • 1.06%

Company Name

Holding

Boston Scientific Corp 3 %
Alcon Inc 1.85 %
More 1.85 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

-16.37%

5 Year

13.33%

Best

25.05%

2019

Worst

-28.47%

2022

Alpha

VRGOX S&P 500

Chart +